Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-03

FDA Approved: TEMOZOLOMIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves a supplemental application for Temozolomide from Accord Healthcare Inc., a generic cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

SUPPL AP for TEMOZOLOMIDE (TEMOZOLOMIDE)